Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Annual Review of Immunology
|
March 4, 2025
The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and Repair
Chrysante S Iliakis, Stefania Crotta, Andreas Wack
Nature Communications
|
May 22, 2014
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson, Stefania Crotta, Teresa M McCabe, et al.
Journal of Hepatology
|
December 18, 2009
Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection
Stefania Crotta, Michela Brazzoli, Diego Piccioli, et al.
International Journal of Hepatology
|
October 19, 2011
Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virions
Alessia Bianchi, Stefania Crotta, Michela Brazzoli, et al.
EMBO Reports
|
August 13, 2015
TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection
Gregory T Ellis, Sophia Davidson, Stefania Crotta, et al.
Journal of Virology
|
June 27, 2008
CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes
Michela Brazzoli, Alessia Bianchi, Sara Filippini, et al.
The Journal of Experimental Medicine
|
September 2, 2021
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
Julie C F Rappe, Katja Finsterbusch, Stefania Crotta, et al.
Nature Communications
|
February 13, 2023
Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidation
Stefania Crotta, Matteo Villa, Jack Major, et al.
Journal of Hepatology
|
November 17, 2006
Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line
Michela Brazzoli, Stefania Crotta, Alessia Bianchi, et al.
EMBO Molecular Medicine
|
August 14, 2016
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment
Sophia Davidson, Teresa M McCabe, Stefania Crotta, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Annual Review of Immunology
|
March 4, 2025
The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and Repair
Chrysante S Iliakis, Stefania Crotta, Andreas Wack
Nature Communications
|
May 22, 2014
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson, Stefania Crotta, Teresa M McCabe, et al.
Journal of Hepatology
|
December 18, 2009
Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection
Stefania Crotta, Michela Brazzoli, Diego Piccioli, et al.
International Journal of Hepatology
|
October 19, 2011
Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virions
Alessia Bianchi, Stefania Crotta, Michela Brazzoli, et al.
EMBO Reports
|
August 13, 2015
TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection
Gregory T Ellis, Sophia Davidson, Stefania Crotta, et al.
Journal of Virology
|
June 27, 2008
CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes
Michela Brazzoli, Alessia Bianchi, Sara Filippini, et al.
The Journal of Experimental Medicine
|
September 2, 2021
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
Julie C F Rappe, Katja Finsterbusch, Stefania Crotta, et al.
Nature Communications
|
February 13, 2023
Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidation
Stefania Crotta, Matteo Villa, Jack Major, et al.
Journal of Hepatology
|
November 17, 2006
Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line
Michela Brazzoli, Stefania Crotta, Alessia Bianchi, et al.
EMBO Molecular Medicine
|
August 14, 2016
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment
Sophia Davidson, Teresa M McCabe, Stefania Crotta, et al.
Page
of 4